GPR34

GPR34 is a widely‑expressed GPCR receptor that binds lyso‑phosphatidylserine (lysoPS). It governs immune regulation, neuroinflammatory response and tumor microenvironment signaling, and participates in immune cell function and lipid‑mediated signal transduction. The lysoPS/GPR34 axis drives downstream cellular signaling cascades, and represents a key therapeutic target for inflammation‑related disorders and oncology. Our GPR34 stable CHO‑K1 cell lines have been validated in cAMP assays to support your drug discovery programs.